[Federal Register Volume 85, Number 98 (Wednesday, May 20, 2020)]
[Notices]
[Pages 30709-30710]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-10891]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Injury 
Prevention and Control

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting for the Board of Scientific Counselors 
(BSC), National Center for Injury Prevention and Control (NCIPC). This 
meeting is open to the public, limited only by the ports available. 
There will be 2,000 telephone ports available. There will be 40 minutes 
allotted for oral public comments at the end of the open session from 
12:20 p.m. to 1:00 p.m. on July 22, 2020.
    The public is encouraged to register to participate by telephone 
and/or provide oral public comment using the registration form 
available at the link provided: https://www.surveymonkey.com/r/NVV9XM2.
    Individuals registered to provide oral public comment will be 
called upon to speak based on the order of registration. After persons 
who have registered have spoken, any remaining time in the oral public 
comment period will be used for members of the public who have not 
registered to speak but wish to offer comment. Individuals making oral 
public comment during the meeting will have a 2-minute speaking limit 
to allow for as many comments as possible.

DATES: The meeting will be held on July 22, 2020, 10:00 a.m. to 1:00 
p.m., EDT (OPEN) and July 22, 2020, 1:45 p.m. to 4:15 p.m., EDT 
(CLOSED).

ADDRESSES: Teleconference 1-800-369-3110; Participant Code 7563795.

FOR FURTHER INFORMATION CONTACT: Gwendolyn H. Cattledge, Ph.D., 
M.S.E.H., Deputy Associate Director for Science, NCIPC, CDC, 4770 
Buford Highway NE, Mailstop S106-9, Atlanta, GA 30341, Telephone (770) 
488-3953, Email address: [email protected].

SUPPLEMENTARY INFORMATION: Portions of the meeting as designated above 
will be closed to the public in accordance with provisions set forth in 
Section 552b(c)(4) and (6), Title 5 U.S.C., and the Determination of 
the Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, CDC pursuant to Public Law 92-463.
    Purpose: The Board will: (1) Conduct, encourage, cooperate with, 
and assist other appropriate public health authorities, scientific 
institutions, and scientists in the conduct of research, 
investigations, experiments, demonstrations, and studies relating to 
the causes, diagnosis, treatment, control, and prevention of physical 
and mental diseases, and other impairments; (2) assist States and their 
political subdivisions in preventing and suppressing communicable and 
non-communicable diseases and other preventable conditions and in 
promoting health and well-being; and (3) conduct and assist in research 
and control activities related to injury. The BSC, NCIPC makes 
recommendations regarding policies, strategies, objectives, and 
priorities; reviews progress toward injury prevention goals; and 
provides evidence in injury prevention-related research and programs. 
The Board also provides advice on the appropriate balance of intramural 
and extramural research, as well as the structure, progress and 
performance of intramural programs. The Board is designed to provide 
guidance on extramural scientific program matters, including the: (1) 
Review of extramural research concepts for funding opportunity 
announcements; (2) conduct of Secondary Peer Review of extramural 
research grants, cooperative agreements, and contracts applications 
received in response to the funding opportunity announcements as they 
relate to the

[[Page 30710]]

Center's programmatic balance and mission; (3) submission of secondary 
review recommendations to the Center Director of applications to be 
considered for funding support; (4) review of research portfolios; and 
(5) review of program proposals.
    Matters To Be Considered: The open portion of the agenda will 
include an update on the formation of the BSC, NCIPC Opioid Workgroup, 
a presentation focused on opportunities for stakeholder engagement on 
management of acute and chronic pain, and an update on the CDC Opioid 
Prescribing Estimates Project. All presentations will be followed by 
discussion by the BSC. The closed portion of the agenda will focus on 
the secondary peer review of extramural research grant applications 
received in response to two (2) Notice of Funding Opportunities 
(NOFOs): RFA-CE20-001--``Evaluating Practice-Based Programs, Policies, 
and Practices from CDC's Rape Prevention and Education (RPE) Program: 
Expanding the Evidence to Prevent Sexual Violence''; and RFA-CE20-003--
``Research Grants for Preventing Violence and Violence-Related Injury'' 
(R01). Agenda items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, CDC, has been delegated the authority to sign 
Federal Register notices pertaining to announcements of meetings and 
other committee management activities, for both the Centers for Disease 
Control and Prevention and the Agency for Toxic Substances and Disease 
Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-10891 Filed 5-19-20; 8:45 am]
 BILLING CODE 4163-18-P